QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 looking-into-epizymes-return-on-capital-employed

According to Benzinga Pro data, during Q2, Epizyme (NASDAQ:EPZM) posted sales of $27.53 million. Earnings were up 35.6%, but Ep...

 epizyme-q2-earnings-insights
Epizyme: Q2 Earnings Insights
08/09/2022 12:56:57

  Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors ne...

 epizyme-q2-eps-021-up-from-063-yoy

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.21) per share. This is a 66.67 percent increase over losses of $(0.63) p...

 benzingas-top-ratings-upgrades-downgrades-for-june-28-2022

Upgrades

 epizyme-granted-us-patent-11370781-combination-therapy-for-treating-cancer

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5571&...

 cowen--co-downgrades-epizyme-to-market-perform-announces-15-price-target

Cowen & Co. analyst Joseph Thome downgrades Epizyme (NASDAQ:EPZM) from Outperform to Market Perform and announces $1.5 p...

 this-healthcare-stock-jumps-around-188-heres-83-biggest-movers-from-yesterday

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court over...

 why-is-neurosense-therapeutics-surging-by-70-46-stocks-moving-in-mondays-mid-day-session

 Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

 the-daily-biotech-pulse-chmp-backs-astrazenecas-breast-cancer-therapies-ipsen-buys-epizyme-fda-holds-for-nuvation-bio-astellas-studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

 benzingas-top-ratings-upgrades-downgrades-for-june-27-2022

Upgrades

 why-epizyme-shares-are-soaring-today

Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement ...

 wedbush-downgrades-epizyme-to-neutral

Wedbush analyst David Nierengarten downgrades Epizyme (NASDAQ:EPZM) from Outperform to Neutral.

 ipsen-scoops-up-blood-cancer-focused-epizyme---read-why

Ipsen SA (OTC: IPSEY) has 

 epizyme--20-stocks-moving-in-mondays-pre-market-session

Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Fr...

Core News & Articles

Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger ag...

 76-biggest-movers-from-yesterday-ocean-bio-chem-athira-pharma-and-more

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announc...

 40-stocks-moving-in-wednesdays-mid-day-session

 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired b...

 20-stocks-moving-in-tuesdays-pre-market-session

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company rea...

 93-biggest-movers-from-yesterday
93 Biggest Movers From Yesterday
06/14/2022 07:58:38

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company an...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION